Cover Image

Radiation therapy for primary central nervous system lymphoma

Yuta Shibamoto
  • Yuta Shibamoto
    Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan | yshiba@med.nagoya-cu.ac.jp

Abstract

Up until the late 1970s, radiation therapy played an important role in the treatment of primary central nervous system lymphoma (PCNSL) but more recently its role has changed due to the increased use of systemic chemotherapy. In this article, the current status of radiotherapy for PCNSL and optimal forms of radiotherapy, including the treatment volume and radiation dose, are discussed. Data from nationwide Japanese surveys of PCNSL patients treated with radiation therapy suggest that the prognosis of PCNSL patients improved during the 1990s, in part due to the use of high-dose methotrexate-containing chemotherapy. The prognosis of patients treated with radiation alone also improved. Radiotherapy still seems to play an important role in the attempt to cure this disease.

Keywords

brain neoplasm, lymphoma, central nervous system, radiotherapy, chemotherapy.

Full Text

PDF
HTML
Submitted: 2013-07-22 07:30:02
Published: 2013-09-03 12:11:04
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
2737

Views:
PDF
426
HTML
554

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2013 Yuta Shibamoto

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185